Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.340
-0.030 (-1.27%)
At close: May 26, 2026, 4:00 PM EDT
2.370
+0.030 (1.28%)
After-hours: May 26, 2026, 7:33 PM EDT
Daré Bioscience Employees
As of December 31, 2025, Daré Bioscience had 24 total employees, including 21 full-time and 3 part-time employees. The number of employees increased by 1 or 4.35% compared to the previous year.
Employees
24
Change (1Y)
1
Growth (1Y)
4.35%
Revenue / Employee
$48,218
Profits / Employee
-$500,869
Market Cap
35.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | 1 | 4.35% | 21 | 3 |
| Dec 31, 2024 | 23 | -3 | -11.54% | 21 | 2 |
| Dec 31, 2023 | 26 | -4 | -13.33% | 23 | 3 |
| Dec 31, 2022 | 30 | 2 | 7.14% | 25 | 5 |
| Dec 31, 2021 | 28 | 5 | 21.74% | 20 | 8 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Evaxion | 46 |
| Boundless Bio | 28 |
| Actinium Pharmaceuticals | 25 |
| Veru Inc. | 20 |
| ABVC BioPharma | 19 |
| Tevogen Bio Holdings | 18 |
| Lantern Pharma | 16 |
DARE News
- 13 hours ago - Dare Bioscience receives NIH funding award notice to advance DARE-HPV - TheFly
- 13 hours ago - Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer - GlobeNewsWire
- 8 days ago - Dare Bioscience initiates DARE-HPV clinical study - TheFly
- 8 days ago - Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies - GlobeNewsWire
- 12 days ago - Daré Bioscience Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - Daré Bioscience Quarterly report: Q1 2026 - Filings
- 12 days ago - Daré Bioscience Earnings release: Q1 2026 - Filings
- 12 days ago - Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire